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MINI-ABSTRACT 
A decade from publication, approximately one in ten surgical devices described in the 
literature made the leap from the laboratory to a first-in-human study. Clinical involvement 
was a significant predictor of translation; devices developed with clinical collaboration were 
over six times more likely to be translated than those without.  
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STRUCTURED ABSTRACT 
Objective: To determine the rate and extent of translation of innovative surgical devices from 
the laboratory to first-in-human studies, and to evaluate the factors influencing such 
translation. 
Summary Background Data: Innovative surgical devices have preceded many of the major 
advances in surgical practice. However, the process by which devices arising from academia 
find their way to translation remains poorly understood. 
Methods: All biomedical engineering journals, and the five basic science journals with the 
highest impact factor, were searched between January 1993 and January 2000 using the 
Boolean search term “surgery OR surgeon OR surgical”. Articles were included if they 
described the development of a new device and a surgical application was described. A 
recursive search of all citations to the article was performed using the Web of Science 
(Thompson-Reuters, New York, USA) to identify any associated first-in-human studies 
published by January 2015. Kaplan-Meier curves were constructed for the time first-in-
human studies. Factors influencing translation were evaluated using Log Rank and Cox 
proportional hazards models. 
Results: 8,297 articles were screened, and 205 publications describing unique devices 
identified.  The probability of a first-in-human at 10 years was 9.8%. Clinical involvement 
was a significant predictor of a first-in-human study (p = 0.02); devices developed with early 
clinical collaboration were over six times more likely to be translated than those without (RR 
6.5 [95% CI 0.9 - 48]). 
Conclusions: These findings support initiatives to increase clinical translation through 
improved interactions between basic, translational, and clinical researchers. 
Key words: Surgery; Innovation; Technology; Diffusion of Innovations 
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INTRODUCTION 
The development, evaluation, and adoption of innovative surgical devices are essential to the 
advancement of clinical practice.1 Despite the enormous importance of these devices to 
human health, the process by which biomedical innovations arising from academia find their 
way to translation remains poorly understood.2 Any earnest attempt to foster a more 
nourishing environment for translational research should be predicated on a better 
appreciation of this process.  
The translation of an innovative surgical device has been described as a continuum of 
activities, punctuated by several well-defined chasms: (1) the development of the device 
culminating in a first-in-human study, (2) the evaluation of the device in clinical trials 
resulting in a license for use, and (3) the adoption of the device by surgeons.3  
Previous studies on the translation of biomedical innovation generally report a long lag 
between innovation and translation – approximately 17 years – and suggest that industry 
collaboration is the most important predictor of translation.4, 5 However, these studies largely 
focus on drug rather than device innovation, and on their evaluation and adoption rather than 
their development. To address this shortfall, we explored the process by which surgical 
devices described in the biomedical literature make the leap to first-in-human studies. 
A MULTITUDE OF INNOVATIVE SURGICAL DEVICES ARISE FROM 
ACADEMIA 
We used the ISI Web of Knowledge Journal Citation Report (Thompson-Reuters, New York, 
USA) to identify all biomedical biomedical engineering journals, and the five basic science 
journals with the highest impact factor. These journals were then searched on the NCBI 
PubMed (NCBI, Maryland, USA) and IEEE Xplore (IEEE, New York, USA) databases 
between January 1993 and January 2000 using the Boolean search term “surgery OR surgical 
OR surgeon” to capture publications describing innovative surgical devices.  
Devices were defined according to the US Food and Drug Administration as “...products 
which do not achieve their primary intended purposes through chemical actions within or on 
the body of man or other animals and which are not dependent upon being metabolised for 
the achievement of any of their primary intended purposes”. When multiple publications 
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were found that described the same surgical device, the earliest publication was used for 
subsequent analysis. 
In all, 8,297 article titles and abstracts were screened, of which 205 described innovative 
surgical devices and were included. The original articles were most commonly published in 
ASAIO (57/205; 27.8%) and Artificial Organs (55/205; 26.8%), and the majority of the 
corresponding authors were found in the USA (59/205; 28.8%) and Japan (56/205; 27.3%). A 
multitude of devices were observed, but most were implants (149/205; 72.7%) and 
constructed for a specific disease or application (179/205; 87.3%). 
FEW DEVICES MAKE THE LEAP FROM THE LABORATORY TO A FIRST-IN-
HUMAN STUDY 
We then determined the rate and extent to which innovative surgical devices made the leap 
from the laboratory to a first-in-human study. A publication was considered to describe the 
translation of a particular device if it was clearly referenced in the manuscript and an 
uninterrupted citation chain to the original article could be identified. 
For each innovative surgical device, we searched through all citations to the corresponding 
article published before January 2015 using the Web of Science (Thompson-Reuters, New 
York, USA). All citations to an article were sorted according to their date of publication 
(oldest first) and screened to find the first clinical publication using the device. If no clinical 
publications were found, citations were then screened to identify articles by any of the 
original authors describing subsequent development of the device and, if so, the process was 
repeated.  
Overall, 24/205 (11.7%) of innovative surgical devices were associated with a first-in-human 
study. Kaplan-Meier curves were constructed, and the probability of a device resulting in a 
first-in-human study at 5, 10, and 20 years was 7.8%, 9.8%, and 11.8% respectively (Figure 
1).  
Contopoulos-Ionnidis et al evaluated the translation of promising basic science research but, 
unlike the present study, they focused on drug rather than device innovation, and included 
work that had already been used in humans.5 They concluded that even the most promising 
basic science research, published in journals with the highest impact factors, was rarely 
translated; 5.0% of innovations were licensed, and 1.0% were widely adopted. In the present 
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study, the leap from initial device description to first-in-human study represented a major 
barrier.  
CLINICAL COLLABORATION IS KEY TO NOURISHING THE 
TRANSLATIONAL RESEARCH ENVIRONMENT 
Finally, we evaluated the factors influencing translation (clinical involvement or not; industry 
involvement or not; instrument or implant; single disease or broader disease category) using 
Log Rank (Mantel-Cox) and Cox proportional hazards models. The extent of clinical 
involvement was a significant predictor of a first-in-human study (p = 0.02) (Figure 1). 
Devices developed with early clinical collaboration were over six times more likely to be 
translated than those without (RR 6.5 [95% CI 0.9 - 48]). Other variables, including the 
extent of industry involvement, were not significantly associated with translation (p > 0.1). 
In recent years, there have been several initiatives to increase the translation of innovative 
surgical devices.6, 7 This study is the first to provide quantitative evidence to support the idea 
that clinical collaboration is associated with more rapid and extensive translation. 
Interestingly, and in contrast to previous studies, industry collaboration was not associated 
with increased translation.5 We speculate that the reason for this disparity lies in the varying 
role of clinical and industry collaboration through the continuum of translation. Early 
translation may be more reliant on clinicians to drive first-in-human and early clinical trials, 
while later translation may be more reliant on industry to navigate the complex and costly 
licensing pathway, and market devices to the wider clinical community.  
In summary, improved interactions between basic, translational and clinical researchers may 
facilitate the translation of innovative surgical devices from the laboratory to the operating 
room. In the words of Henry Ford: Coming together is a beginning; keeping together is 
progress; working together is success. 
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Figure 1. Kaplan-Meier graphs illustrating (a) the overall probability of a first-in-human 
publication over time, and (b) the Log Rank (Mantel-Cox) probability of a first-in-human 
publication over time stratified according whether there was clinical involvement (green line) 
or not (blue line). 
 
